# US 2016/0256393 A1 · Gastroretentive drug formulation and delivery systems and their method of preparation using functionalized calcium carbonate

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0256393 A1
- Document ID: US20160256393A1
- Status: Published application
- Kind: A1
- Application number: 15/156,622
- Filed: 2016-05-17
- Published: 2016-09-08
- Earliest claimed: 2012-10-12
- Assignees: Omya International AG
- Applicants: Omya International AG
- Inventors: Daniel E. Gerard; Joachim Schoelkopf; Patrick A.C. Gane; Veronika Anna Eberle; Alles Rainer; Maxim Puchkov; Jörg Huwyler
- Web page: https://patentgrep.com/patent/US20160256393A1

## CPC

- A61K 9/1611: {Inorganic compounds}
- A61J 3/10: into the form of compressed tablets (tablet presses B30B11/00)
- A61K 9/0065: {Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus}
- A61K 9/1617: {Organic compounds, e.g. phospholipids, fats}
- A61K 9/1641: {obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers}
- A61K 9/1652: {Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin (homeopathic globules A61K9/1623)}
- A61K 9/1682: {Processes}
- A61K 9/2009: {Inorganic compounds}
- A61K 9/2013: {Organic compounds, e.g. phospholipids, fats}
- A61K 9/2031: {obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers}
- A61K 9/2054: {Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose}
- A61K 9/2095: {Tabletting processes}
- A61K 31/522: having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61J: CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE

## Abstract

An instantly floating gastroretentive drug formulation comprising at least one functionalized natural and/or synthetic calcium carbonate-comprising mineral and at least one pharmaceutically active ingredient and at least one formulating aid wherein said functionalized natural or synthetic calcium carbonate is a reaction product of natural or synthetic calcium carbonate with carbon dioxide and one or more acids, wherein the carbon dioxide is formed in situ by the acid treatment and/or is supplied from an external source.

## Claims

### Claim 1

A method for producing an instantly floating gastroretentive formulation comprising the steps:
a) providing a functionalized natural or synthetic calcium carbonate comprising mineral (FCC), wherein the functionalized natural or synthetic calcium carbonate is a reaction product of natural or synthetic calcium carbonate with carbon dioxide and one or more acids, wherein the carbon dioxide is formed in situ by the acid treatment and/or is supplied from an external source;
b) providing at least one pharmaceutically active ingredient;
c) providing at least one formulating aid;
d) mixing the compounds provided in steps a), b) and c); and
e) granulating the mixture obtained in step d) by way of melt, dry or wet granulation or roller compaction.

### Claim 2 (depends on 1)

The method according to claim 1, wherein a part of the formulation aid of step c) is first mixed with the functionalized calcium carbonate (FCC) of step a) and the at least one pharmaceutically active ingredient of step b), and the remaining portion of the formulation aid is then added to the mixture, followed by the granulation step e).

### Claim 3 (depends on 1)

The method according to claim 1, wherein the functionalized calcium carbonate (FCC) is prepared from natural calcium carbonate selected from the group consisting of marble, calcite, chalk, limestone, dolomite, and any mixture thereof.

### Claim 4 (depends on 1)

The method according to claim 1, wherein the functionalized calcium carbonate (FCC) is prepared from synthetic calcium carbonate that is precipitated calcium carbonate (PCC) having one or more aragonitic, vateritic, prismatic, rhombohedral or scalenohedral forms.

### Claim 5 (depends on 1)

The method according to claim 1, wherein the one or more acids is selected from the group consisting of hydrochloric acid, sulfuric acid, sulfurous acid, hydrosulfate, phosphoric acid, phosphoric acid in combination with acetic, formic or citric acid or acid salts thereof, and any mixture thereof.

### Claim 6 (depends on 1)

The method according to claim 1, wherein the one or more acids is phosphoric acid.

### Claim 7 (depends on 1)

The method according to claim 1, wherein the functionalized natural or synthetic calcium carbonate has a BET specific surface area of from 5 m2/g to 200 m2/g, measured using nitrogen and the BET method according to ISO 9277:2010.

### Claim 8 (depends on 1)

The method according to claim 1, wherein the functionalized natural or synthetic calcium carbonate has a BET specific surface area of from 20 m2/g to 150 m2/g, measured using nitrogen and the BET method according to ISO 9277:2010.

### Claim 9 (depends on 1)

The method according to claim 1, wherein the functionalized natural or synthetic calcium carbonate has a BET specific surface area of from 40 m2/g to 100 m2/g, measured using nitrogen and the BET method according to ISO 9277:2010.

### Claim 10 (depends on 1)

The method according to claim 1, wherein the functionalized natural or synthetic calcium carbonate has a weight median grain diameter of from 0.1 to 50 μm, measured using Malvern Mastersizer X long bed.

### Claim 11 (depends on 1)

The method according to claim 1, wherein the functionalized natural or synthetic calcium carbonate has a weight median grain diameter of from 0.5 to 25 μm, measured using Malvern Mastersizer X long bed.

### Claim 12 (depends on 1)

The method according to claim 1, wherein the functionalized natural or synthetic calcium carbonate has a weight median grain diameter of from 0.8 to 20 μm, measured using Malvern Mastersizer X long bed.

### Claim 13 (depends on 1)

The method according to claim 1, wherein the functionalized natural or synthetic calcium carbonate has a weight median grain diameter of from 1 to 15 μm, measured using Malvern Mastersizer X long bed.

### Claim 14 (depends on 1)

The method according to claim 1, wherein the least one pharmaceutically active ingredient is an active agent or an inactive precursor that is synthetic-, semi-synthetic or of natural origin or any combination thereof.

### Claim 15 (depends on 1)

The method according to claim 1, wherein the at least one formulating aid is a film forming compound and/or composition.

### Claim 16 (depends on 15)

The method according to claim 15, wherein the film forming compound and/or composition is selected from the group consisting of hydrophilic film forming excipients, lipophilic film forming excipients, or any combination thereof.

### Claim 17 (depends on 1)

The method according to claim 1, wherein the at least one formulating aid is a hydrophilic film forming excipient selected from group consisting of water soluble polyethylene glycols, polyethylene oxides, polypropylene glycols, polypropylene oxides or any combination thereof, polymers having a weight average molecular weight from 2,000 Da to 20,000,000 Da, chitosan, polymers of acrylic acid, polyvinylpyrrolidon, insoluble cross-linked polyvinylpyrollidones, homopolymers of N-vinyl-2-pyrrolidone, modified cellulose gums, starch glycolates, pregelatinized starch, sodium carboxymethyl starch, low-substituted hydroxypropyl cellulose, alkyl-, hydroxyalkyl-, carboxyalkyl-cellulose esters, hydroxpropyl methyl cellulose phthalate, carboxymethylcellulose salts, alginates, ion exchange resins, gums, chitin, clays, gellan gum, crosslinked polacrillin copolymers, agar, gelatin, dextrines, shellac, and any combination thereof.

### Claim 18 (depends on 1)

The method according to claim 1, wherein the at least one formulating aid is a lipophilic film forming excipient selected from the group consisting of hydrogenated vegetable, castor oils, mineral oils, waxes fatty acids and fatty acid salts with a carbon chain lengths from C6 to C20, being branched, un-branched, unsaturated, partially saturated, and any combination thereof, magnesium and/or calcium stearate, paraffin, cetyl alcohol, cetyl stearyl alcohol, glyceril monostearate, lanolin, lanolin alcohols, polyethylene glycol ethers of n-alkanols, polyoxyethylene castor oil derivates, polyoxyethylene sorbitan fatty acid esters, polyethylene stearates, sorbitan esters, stearyl alcohol, glycerol dibehenate, sodium stearyl fumarate, glycerol distearate, and any combination thereof.

### Claim 19 (depends on 16)

The method according to claim 16, wherein the film forming excipients are present in an amount from 1 wt % to 60 wt %, based in the total weight of the formulation.

### Claim 20 (depends on 1)

The method according to claim 1, wherein a water soluble acid is added prior to step d).

### Claim 21 (depends on 20)

The method according to claim 20, wherein the water soluble solid acid is selected from the group consisting of citric acid, fumaric acid, tartaric acid, malic acid, and any combination thereof.

### Claim 22 (depends on 20)

The method according to claim 20, wherein the acid is present in amounts of up to 10 wt %, based on the total weight of the formulation.

### Claim 23 (depends on 20)

The method according to claim 20, wherein the acid is present in amounts of up to 8 wt %, based on the total weight of the formulation.

### Claim 24 (depends on 20)

The method according to claim 20, wherein the acid is present in amounts of up to 5 wt %, based on the total weight of the formulation.

### Claim 25 (depends on 1)

The method according to claim 1, wherein the granulation step e) is followed by a compacting step f).

### Claim 26 (depends on 25)

The method according to claim 25, wherein the compacting step f) is pelletizing or tableting.
